Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
Saguenay, Quebec, G7X 7X2, Canada
NCT Number: NCT04001920
A strength and endurance training program was conducted in adults with myotonic dystrophy type 1 (DM1). Participants underwent a 12-week/18-session supervised training program consisted of 6 exercises: elbow flexion/extension, shoulder horizontal adduction, leg press, and knee flexion/extension. To offer a complete training program aimed at improving function it was divided: the first 6 weeks were dedicated to strength-training, whereas the following weeks focused on endurance-training. To evaluate the effects of the training program, participants completed maximal strength, endurance and functional evaluations. Volunteers could also add a muscle biopsy at the beginning and the end of the program to evaluate physiological parameters.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Saguenay, Quebec, G7X 7X2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-week, 18-session training program. To offer a complete training program aimed at improving function it was divided : the first 6 weeks were dedicated to strength-training (2 sets of 6 repetitions at 80% of 1-RM), whereas the following weeks focused on endurance-training (1 set of 25 repetitions at 40% of 1-RM).
Time frame: Before and after the 12-week training program
Changes in knee extensor maximal muscle strength evaluated by quantified muscle testing with a handheld dynamometer.
Time frame: Before and after the 12-week training program
Walking endurance change measured by the 6 minute walking test distance.
Time frame: Before and after the 12-week training program
Functional capacity evaluated by 18 functional tests
Time frame: Before and after the 12-week training program
Sprint capacity changes measured by the running-base anaerobic sprint test
Time frame: Before and after the 12-week training program
Fatigue questionnaire: 9-item questionnaire rated on a scale from 1 to 7 for each item. A score a higher score means more fatigue.
Time frame: Before and after the 12-week training program
8-item questionnaire, rated on a scale from 0 to 3 for each item, the higher the score, the more the patient has daytime sleepiness.
Time frame: Before and after the 12-week training program
10-item questionnaire about stumbles and falls. All items are rated on a 10-point scale. A higher score means a higher fear of falling. A score over 70 means a significant fear of falling.
Time frame: Before and after the 12-week training program
36-item quality of life questionnaire. The final score is calculated on a total of 100 where the lower the score, the more disability. A score of 100 means no disability.
Time frame: Before and after the 12-week training program
Life habits questionnaire Assessment of life habits is a 77-item questionnaire with a scale from 0 to 9 for each item. A higher score means no disability and a low score means more disability.
Time frame: Before and after the 12-week training program for volunteers
To assess changes in muscle fiber size
Time frame: Before and after the 12-week training program for volunteers
To assess changes in muscle fiber typing
Time frame: Before and after the 12-week training program for volunteers
To assess changes in muscle centrally nucleated fibers proportion
Time frame: Before and after the 12-week training program for volunteers
To assess changes in muscle fiber leucocyte infiltration
Cynthia Gagnon
Other
Effects of a Multiple Component Training Program on Muscles, Maximal Muscle Strength, Endurance and Functional Performance in Adults With Myotonic Dystrophy Type 1: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05027269
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
Los Angeles, California, United States
View Trial DetailsNCT06204809
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Irvine, California, United States
View Trial DetailsNCT05479981
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
Los Angeles, California, United States
View Trial DetailsNCT03424460
Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Paris, Île-de-France Region, France
View Trial Details